Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.

MLA

Siris, E., et al. “Comparative Study of Alendronate versus Etidronate for the Treatment of Paget’s Disease of Bone.” The Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 3, Mar. 1996, pp. 961–67. EBSCOhost, https://doi.org/10.1210/jcem.81.3.8772558.

APA

Siris, E., Weinstein, R. S., Altman, R., Conte, J. M., Favus, M., Lombardi, A., Lyles, K., McIlwain, H., Murphy, W. A., Jr, Reda, C., Rude, R., Seton, M., Tiegs, R., Thompson, D., Tucci, J. R., Yates, A. J., & Zimering, M. (1996). Comparative study of alendronate versus etidronate for the treatment of Paget’s disease of bone. The Journal of Clinical Endocrinology and Metabolism, 81(3), 961–967. https://doi.org/10.1210/jcem.81.3.8772558

Chicago

Siris, E, R S Weinstein, R Altman, J M Conte, M Favus, A Lombardi, K Lyles, et al. 1996. “Comparative Study of Alendronate versus Etidronate for the Treatment of Paget’s Disease of Bone.” The Journal of Clinical Endocrinology and Metabolism 81 (3): 961–67. doi:10.1210/jcem.81.3.8772558.